DERMFREE ORIGINAL NASAL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DERMFREE ORIGINAL NASAL
Generic name: NAPHAZOLINE HCL 0.05%ORIGINAL NASAL
Manufacturer: Jiangxi Yudexi Pharmaceutical Co., LTD
Product type: HUMAN OTC DRUG
SPL set ID: 4a4d3a2b-a4ed-c736-e063-6394a90a96df
SPL ID: 572bb880-5d41-7d4b-e063-6394a90ac312
Version: 2
Effective date: 2026-07-21
Source export date: 2026-10-12
Source partition: 2
Source file: https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/4760f38f2bcb10aa20ddbadb42b270d31e9f2a8024440d3af3dec8d11feb92ec/drug-label-0002-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:28:17

Harmonized routes table
Harmonized routes
NASAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M012	openfda.application_number
brand name		DERMFREE ORIGINAL NASAL	openfda.brand_name
generic name		NAPHAZOLINE HCL 0.05%ORIGINAL NASAL	openfda.generic_name
manufacturer name		Jiangxi Yudexi Pharmaceutical Co., LTD	openfda.manufacturer_name
ndc	package	85248-112-01	openfda.package_ndc
ndc	product	85248-112	openfda.product_ndc
ndc11	package	85248011201	derived:openfda.package_ndc
rxcui		1046610	openfda.rxcui
spl id		572bb880-5d41-7d4b-e063-6394a90ac312	id
spl set id		4a4d3a2b-a4ed-c736-e063-6394a90a96df	set_id
unii		MZ1131787D	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings 1.Do not use if you are allergic to the ingredients. 2.Ask a doctor before use if you have Heart disease、High blood pressure、Thyroid disease、Diabetes、Trouble urinating due to enlarged prostate gland 3.When using this product Do not exceed recommended dosage

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.